Identification of pain categories associated with change in pain in patients receiving placebo: Data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis
JournalBMC Musculoskeletal Disorders
PublisherBioMed Central Ltd.
MetadataShow full item record
AbstractBackground: Pain is the principal clinical symptom of osteoarthritis (OA), and development of safe and effective analgesics for OA pain is needed. Drug development of new analgesics for OA pain is impaired by substantial change in pain in patients receiving placebo, and more data describing clinical characteristics and pain categories particularly associated with this phenomenon is needed. The purpose of this post-hoc analysis was to investigate clinical characteristics and pain categories and their association with radiographic progression and placebo pain reduction (PPR) in OA patients as measured the Western Ontario and McMasters Arthritis (WOMAC). Methods: Pooled data from the placebo groups of two phase III randomized clinical trials in patients with knee OA followed for 2 years were analyzed. Differences between individual sub-scores and pain categories of weight-bearing and non-weight bearing pain over time were assessed. Selected patient baseline characteristics were assessed for association with PPR. Association between pain categories and radiographic progression was analyzed. Results: The reduction of pain in placebo-treated patients was significantly higher in the composite of questions related to weight-bearing pain compared to non-weight-bearing pain of the target knee. Baseline BMI, age and JSW were not associated with pain change. Pain reduction was higher in the Target knee, compared to the Non-Target knee at all corresponding time-points. A very weak correlation was found between weight-bearing pain and progression in the non-target knee. Conclusions: These results indicate that the reduction in pain in patients treated with placebo is significantly different between pain categories, as weight-bearing pain was significantly more reduced compared to non-weight-bearing pain. Further research in pain categories in OA is warranted. Trial Registration: NCT00486434 (trial 1) and NCT00704847 (trial 2) Copyright 2018 The Author(s).
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85040768210&doi=10.1186%2fs12891-018-1938-5&partnerID=40&md5=a77676e65c48d478bb4b0efbd818c971; http://hdl.handle.net/10713/9437
- OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.
- Authors: Karsdal MA, Bihlet A, Byrjalsen I, Alexandersen P, Ladel C, Michaels M, Andersen JR, Riis BJ, Kraus V, Bay-Jensen AC, Christiansen C
- Issue date: 2015 Apr
- Radiographic joint space width is correlated with 4-year clinical outcomes in patients with knee osteoarthritis: data from the osteoarthritis initiative.
- Authors: Oak SR, Ghodadra A, Winalski CS, Miniaci A, Jones MH
- Issue date: 2013 Sep
- Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial.
- Authors: Kingsbury SR, Tharmanathan P, Arden NK, Batley M, Birrell F, Cocks K, Doherty M, Edwards CJ, Garrood T, Grainger AJ, Green M, Hewitt C, Hughes R, Moots R, O'Neill TW, Roddy E, Scott DL, Watt FE, Torgerson DJ, Conaghan PG
- Issue date: 2015 Mar 4
- Defining knee pain trajectories in early symptomatic knee osteoarthritis in primary care: 5-year results from a nationwide prospective cohort study (CHECK).
- Authors: Bastick AN, Wesseling J, Damen J, Verkleij SP, Emans PJ, Bindels PJ, Bierma-Zeinstra SM
- Issue date: 2016 Jan
- Knee Pain and Structural Damage as Risk Factors for Incident Widespread Pain: Data From the Multicenter Osteoarthritis Study.
- Authors: Carlesso LC, Segal NA, Curtis JR, Wise BL, Frey Law L, Nevitt M, Neogi T
- Issue date: 2017 Jun